407 related articles for article (PubMed ID: 30209241)
21. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
[TBL] [Abstract][Full Text] [Related]
22. GCN2 contributes to mTORC1 inhibition by leucine deprivation through an ATF4 independent mechanism.
Averous J; Lambert-Langlais S; Mesclon F; Carraro V; Parry L; Jousse C; Bruhat A; Maurin AC; Pierre P; Proud CG; Fafournoux P
Sci Rep; 2016 Jun; 6():27698. PubMed ID: 27297692
[TBL] [Abstract][Full Text] [Related]
23. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2.
Ye J; Palm W; Peng M; King B; Lindsten T; Li MO; Koumenis C; Thompson CB
Genes Dev; 2015 Nov; 29(22):2331-6. PubMed ID: 26543160
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma.
Cormerais Y; Pagnuzzi-Boncompagni M; Schrötter S; Giuliano S; Tambutté E; Endou H; Wempe MF; Pagès G; Pouysségur J; Picco V
J Cell Mol Med; 2019 Apr; 23(4):2711-2718. PubMed ID: 30784173
[TBL] [Abstract][Full Text] [Related]
25. ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation.
Ren P; Yue M; Xiao D; Xiu R; Gan L; Liu H; Qing G
J Pathol; 2015 Jan; 235(1):90-100. PubMed ID: 25142020
[TBL] [Abstract][Full Text] [Related]
26. Decreased ATF4 expression as a mechanism of acquired resistance to long-term amino acid limitation in cancer cells.
Mesclon F; Lambert-Langlais S; Carraro V; Parry L; Hainault I; Jousse C; Maurin AC; Bruhat A; Fafournoux P; Averous J
Oncotarget; 2017 Apr; 8(16):27440-27453. PubMed ID: 28460466
[TBL] [Abstract][Full Text] [Related]
27. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.
Jiang W; Zhou F; Li N; Li Q; Wang L
Int J Clin Exp Pathol; 2015; 8(6):6756-63. PubMed ID: 26261559
[TBL] [Abstract][Full Text] [Related]
28. Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma.
Li J; Zhu S; Tong J; Hao H; Yang J; Liu Z; Wang Y
Neuroreport; 2016 Jan; 27(2):110-5. PubMed ID: 26694942
[TBL] [Abstract][Full Text] [Related]
29. Multiple pathways are involved in the anoxia response of SKIP3 including HuR-regulated RNA stability, NF-kappaB and ATF4.
Rzymski T; Paantjens A; Bod J; Harris AL
Oncogene; 2008 Jul; 27(33):4532-43. PubMed ID: 18408768
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells.
Zhang W; Wang C; Hu X; Lian Y; Ding C; Ming L
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35191522
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of LDHA suppresses tumor progression in prostate cancer.
Xian ZY; Liu JM; Chen QK; Chen HZ; Ye CJ; Xue J; Yang HQ; Li JL; Liu XF; Kuang SJ
Tumour Biol; 2015 Sep; 36(10):8093-100. PubMed ID: 25983002
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma.
Gao S; Tu DN; Li H; Jiang JX; Cao X; You JB; Zhou XQ
Biomed Pharmacother; 2016 Jul; 81():388-393. PubMed ID: 27261617
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.
Jin L; Chun J; Pan C; Alesi GN; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Fan J; Kang S
Oncogene; 2017 Jul; 36(27):3797-3806. PubMed ID: 28218905
[TBL] [Abstract][Full Text] [Related]
34. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation.
Ye J; Mancuso A; Tong X; Ward PS; Fan J; Rabinowitz JD; Thompson CB
Proc Natl Acad Sci U S A; 2012 May; 109(18):6904-9. PubMed ID: 22509023
[TBL] [Abstract][Full Text] [Related]
35. Melanoma brain metastasis is independent of lactate dehydrogenase A expression.
Sundstrøm T; Espedal H; Harter PN; Fasmer KE; Skaftnesmo KO; Horn S; Hodneland E; Mittelbronn M; Weide B; Beschorner R; Bender B; Rygh CB; Lund-Johansen M; Bjerkvig R; Thorsen F
Neuro Oncol; 2015 Oct; 17(10):1374-85. PubMed ID: 25791837
[TBL] [Abstract][Full Text] [Related]
36. Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase.
Mazzio E; Badisa R; Mack N; Cassim S; Zdralevic M; Pouyssegur J; Soliman KFA
Cancer Genomics Proteomics; 2020; 17(5):469-497. PubMed ID: 32859627
[TBL] [Abstract][Full Text] [Related]
37. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
[TBL] [Abstract][Full Text] [Related]
38. MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction.
Pathria G; Verma S; Yin J; Scott DA; Ronai ZA
EMBO Rep; 2021 Mar; 22(3):e51436. PubMed ID: 33554439
[TBL] [Abstract][Full Text] [Related]
39. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.
Hassanein M; Hoeksema MD; Shiota M; Qian J; Harris BK; Chen H; Clark JE; Alborn WE; Eisenberg R; Massion PP
Clin Cancer Res; 2013 Feb; 19(3):560-70. PubMed ID: 23213057
[TBL] [Abstract][Full Text] [Related]
40. Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells.
Smith B; Schafer XL; Ambeskovic A; Spencer CM; Land H; Munger J
Cell Rep; 2016 Oct; 17(3):821-836. PubMed ID: 27732857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
